Find Reports

Select Report Type

Reimbursement Review

Displaying 1 - 25 of 1413

Please scroll or swipe to the right to view the full content.

Title Sort descending	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date	Project Number
dabrafenib trametinib	Tafinlar-Mekinist	dabrafenib trametinib		Advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutation		Cancelled			PC0337-000
Ninlaro for Multiple Myeloma (...	Ninlaro	Ixazomib	pcodr-provfund-10164-ixazomib-ninlaro_mm2nd-beyond.pdf 10164IxazomibMM_fnRec_2019-07-05_ChairApproved_Post_05Jul2019_final.pdf 10164IxazomibMM_fnEGR_NOREDACT-ABBREV_Post_05Jul2019_final.pdf 10164IxazomibMM_fnCGR_REDACT_Post_05Jul2019_final.pdf 10164IxazomibMM_inRec_2019-05-03_Approved_Post_03May2019_final.pdf 10164IxazomibMM_PAGFeedbackSummary_FINAL_Post_5Jul2019_final.pdf 10164IxazomibMM_SubmitterFeedback_2019-05-17_Post_05Jul2019_final.pdf 10164IxazomibMM_PatientFeedback_MC_2019-05-15_Post_05Jul2019_final.pdf 10164IxazomibMM_ClinicianFeedback_CCO_2019-05-16_Post_05Jul2019_final.pdf 10164IxazomibMM_Patient_COI_MC_2018-12-13_Post_05Jul2019_final_Redacted.pdf 10164IxazomibMM_Combined COIs_Post_05Jul2019_final Redacted.pdf	Multiple Myeloma (2nd-beyond)	Do not reimburse	Complete	Nov 30, 2018	Jul 5, 2019	PC0164-000
Niraparib (Zejula) for first l...	Zejula	Niraparib	10224NiraparibOC_fnRec_pERC Chair Approved_Post29Apr2021_final.pdf 10224NiraparibOC_fnEGR_REDACT-ABBREV_Post29Apr2021_final.pdf 10224NiraparibOC_fnCGR_NOREDACT_Post29Apr2021_final.pdf 10224NiraparibOC_inRec_pERC Chair Approved_Post04Mar2021_final.pdf 10224NiraparibOC_PAGFeedbackSummary_Post29Apr2021_final_Redacted.pdf 10224NiraparibOC_SponsorFeedback_Post29Apr2021_final.pdf 10224NiraparibOC_PatientFeedback_OCC_Post29Apr2021_final.pdf 10224NiraparibOC_ClinicianFeedback_CCO_Post29Apr2021_final.pdf 10224NiraparibOC_Patient COI_OCC_Post29Apr2021_final.pdf 10224NiraparibOC_Combined Clinician COIs_Post29Apr2021_final.pdf	First Line OC	Reimburse with clinical criteria and/or conditions	Complete	Sep 21, 2020	Apr 29, 2021	PC0224-000
Pembrolizumab (Keytruda) for R...	Keytruda	Pembrolizumab	10185PembrolizumabRCC_fnRec_2020-03-31_ApprovedpERCChair_Post02Apr2020_final.pdf 10185PembrolizumabRCC_fnEGR_NOREDACT-ABBREV_Post02Apr2020_final.pdf 10185PembrolizumabRCC_fnCGR_REDACT_Post02Apr2020_final.pdf 10185PembrolizumabRCC_PAGFeedbackSummary_Post02Apr2020_final.pdf 10185PembrolizumabRCC_SponsorFeedback_Post24Mar2020_final.pdf 10185PembrolizumabRCC_ClinicianFeedback_CCOGUDAC_Post02Apr2020_final_Redacted.pdf 10185PembrolizumabRCC_PatientInput_KCC_COI_Post02Apr2020_final_Redacted.pdf 10185PembrolizumabRCC_Combined COIs_Post02Apr2020_final_Redacted.pdf Pembrolizumab (Keytruda) RCC – pERC Initial Recommendation	Renal Cell Carcinoma (RCC)	Reimburse with clinical criteria and/or conditions	Complete	Aug 2, 2019	Apr 2, 2020	PC0185-000
Sonidegib (Odomzo) for Basal C...	Odomzo	Sonidegib	10215SonidegibBCC_fnRec_Post29Apr2021_final.pdf 10215SonidegibBCC_fnEGR_NOREDACT-ABBREV_Post29Apr2021_final.pdf 10215SonidegibBCC_fnCGR_NOREDACT_Post29Apr2021_final.pdf 10215SonidegibBCC_inRec_Post04Mar2021_final.pdf 10215SonidegibBCC_PAGFeedbackSummary_Post29Apr2021_final.pdf 10215SonidegibBCC_SponsorFeedback_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_PatientFeedback_Combined_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_ClinicianFeedback_CCO_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_PatientCOI_Combined_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_ClinicianInput_Combined_COIs Post29Apr2021_final_Redacted.pdf	Basal Cell Carcinoma	Do not reimburse	Complete	Jun 19, 2020	Apr 29, 2021	PC0215-000
Xtandi for non-metastatic Cast...	Xtandi	Enzalutamide	pcodr_profund_enzalutamide_xtandi_non-mcrpc_10149.pdf 10149Enzalutamidenm-CRPC_FnRec_EarlyConv_2019-03-26-v4_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_fnCGR_EC_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_fnEGR_EC_NOREDACT-ABBREV_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_InRec_approvedbyChair_NOREDACT_Post_07Mar2019_final.pdf 10149Enzalutamide_nmCRPC_PAGFeedbackSummary_FINAL_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_SubmitterFeedback_2019-03-21_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_ClinicianFeedback_CCO_2019-03-21_Post_26Mar2019_final.pdf 10149Enzalutamide-CRPC_COI_CCSN_Post_26Mar2019_final_Redacted.pdf 10149EnzalutamidenmCRPC_Combined_Clinician_COI_Post_26Mar2019_final.pdf	Non-metastatic castration-resistant prostate cancer (nm-CRPC)	Reimburse with clinical criteria and/or conditions	Complete	Sep 24, 2018	Mar 26, 2019	PC0149-000
Abacavir/lamivudine	Kivexa	Abacavir/lamivudine	cdr_tracking_Kivexa.pdf cdr_complete_Kivexa_Dec605.pdf	HIV infection	List in a similar manner to other drugs in class	Complete	Jul 26, 2005	Dec 7, 2005	SR0038-000
abaloparatide	TBC	abaloparatide		Osteoporosis, postmenopausal women		Withdrawn	Aug 2, 2022		SR0744-000
Abatacept	Orencia	Abatacept	cdr_tracking_Orencia.pdf cdr_complete_Orencia_June-27-2007.pdf	Arthritis, Rheumatoid	List with clinical criteria and/or conditions	Complete	Oct 26, 2006	Jun 27, 2007	SR0084-000
Abatacept	Orencia	Abatacept	cdr_Orencia_New_Indication.pdf cdr_complete_Orencia_Final_April 24_2009.pdf	Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid	List with clinical criteria and/or conditions	Complete	Aug 29, 2008	Apr 22, 2009	SR0145-000
Abatacept	Orencia	Abatacept	cdr_tracking_Orencia_RA.pdf cdr_complete_Orencia-RA_July-22-13_e.pdf	Arthritis, rheumatoid	List with clinical criteria and/or conditions	Complete	Nov 29, 2012	Jul 18, 2013	SR0299-000
Abatacept	Orencia	Abatacept	cdr_tracking_Orencia_Resubmission-1.pdf cdr_complete_Orencia-Resubmission_June-17-2010.pdf	Arthritis, Rheumatoid	List in a similar manner	Complete	Dec 2, 2009	Jun 17, 2010	SR0187-000
abemaciclib	Verzenio	abemaciclib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Adjuvant treatment of HR-positive, HER2-negative early breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Mar 23, 2022	Sep 29, 2022	PC0282-000
abemaciclib	Verzenio	abemaciclib	Recommendation and Reason Patient and Clinician Group input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Adjuvant treatment of HR-positive, HER2-negative early breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Feb 9, 2024	Oct 3, 2024	PC0345-000
abemaciclib	Verzenio	abemaciclib	Patient and Clinician Group input	HR-positive, HER2-negative advanced or metastatic breast cancer		Active	Feb 14, 2025		PC0409-000
abemaciclib	Verzenio	abemaciclib	Patient and Clinician Group input	HR-positive, HER2-negative advanced or metastatic breast cancer		Active	Feb 14, 2025		PC0400-000
Abemaciclib for advanced or me...	Verzenio	Abemaciclib	pcodr-provfund-10161-AbemaciclibVerzenio_ABC.pdf 10161AbemaciclibMBC_fnRec_ApprovedbyChair_v01_2019-07-04_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_fnEGR_NOREDACT-ABBREV_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_fnCGR_NOREDACT_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_inRec_ApprovedbyChair_v01_Post_03May2019_final.pdf 10161AbemaciclibMBC_PAGFeedbackSummary_FINAL_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_SubmitterFeedback_2019-05-17_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_Combined PatientFeedback_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_ClinicianFeedback_CCO_2019-05-16_Post_05Jul2019_final.pdf 10161AbemaciclibMBC_Combined Patient COIs_ Post_05Jul2019_final.pdf 10161AbemaciclibMBC_Combined COIs_Post_05Jul2019_final.pdf	Metastatic Breast Cancer	Reimburse with clinical criteria and/or conditions	Complete	Dec 3, 2018	Jul 5, 2019	PC0161-000
Abiraterone (Zytiga) for Prost...	Zytiga (Resubmission)	Abiraterone		Prostate Cancer Resubmission		Withdrawn	Jul 29, 2019		PC0201-000
abiraterone acetate and predni...	n/a	abiraterone acetate and prednisolone	Recommendation and Reasons Stakeholder Input Stakeholder Feedback on Draft Recommendation Responses to Questions From the Drug Programs Clinical and Pharmacoeconomic Combined Report	High-risk non-metastatic prostate cancer	Reimburse with clinical criteria and/or conditions	Complete	Mar 23, 2022	Sep 8, 2023	PX0291-000 - PC0291-000
abiraterone, prednisone, docet...	N/A	abiraterone, prednisone, docetaxel	Recommendation and Reasons Responses to Questions From the Drug Programs Clinical and Pharmacoeconomic Combined Report Stakeholder Input Stakeholder Feedback on Draft Recommendation	Metastatic castration sensitive prostate cancer (mCSPC)	Reimburse	Complete	Jun 13, 2022	Sep 8, 2023	PX0298-000 - PC0298-000
abobotulinumtoxinA	Dysport Therapeutic	abobotulinumtoxinA	SR0556_Dysport_Therapeutic_Aug_23_18.pdf SR0556_Dysport_Therapeutic_CL_Report.pdf SR0556_Dysport_Therapeutic_PE_Report.pdf SR0556_Dysport_PI_Submissions.pdf	lower limb spasticity	Reimburse with clinical criteria and/or conditions	Complete	Feb 7, 2018	Aug 23, 2018	SR0556-000
abobotulinumtoxinA	Dysport Therapeutic	abobotulinumtoxinA	dysport-therapeutic-product-monograph.pdf SR0517_complete_Dysport_Therapeutic_ULS_Oct_26-17_e.pdf SR0517_Dysport_Therapeutic_CL_Report.pdf SR0517_Dysport_Therapeutic_PE_Report.pdf SR0517_Dysport_ULS_PI_Submissions_Consolidated.pdf	Upper limb spasticity	Reimburse with clinical criteria and/or conditions	Complete	Apr 24, 2017	Oct 24, 2017	SR0517-000
abobotulinumtoxinA	Dysport Therapeutic	abobotulinumtoxinA	cdr_SR0512_Dysport_Therapeutic.pdf SR0512_complete_Dysport_Therapeutic_Jul_28_17_e.pdf SR0512_Dysport_Therapeutic_CL_Report_e.pdf SR0512_Dysport_Therapeutic_PE_Report_e.pdf SR0512_Dysport_Therapeutic_PI_Submissions.pdf	Cervical dystonia	Reimburse with clinical criteria and/or conditions	Complete	Jan 31, 2017	Jul 26, 2017	SR0512-000
Abraxane for Metastatic Pancre...	Abraxane	Nab-paclitaxel	pcodr_profund_nabpaclitaxel_abraxane_pc.pdf pcodr-abraxane-mpc-fn-rec.pdf pcodr-abraxane-mpc-fn-cgr.pdf pcodr-abraxane-mpc-fn-egr.pdf pcodr-abraxane-mpc-in-rec.pdf pcodr-abraxane-mpc-pag-fdk.pdf pcodr-abraxane-mpc-fdk-celgene.pdf pcodr-abraxane-mpc-coi-pcc.pdf pcodr-abraxane-mpc-coi-cc.pdf	Metastatic Pancreatic Cancer	Reimburse with clinical criteria and/or conditions	Complete	Feb 14, 2014	Sep 23, 2014	PC0037-000
abrocitinib	Cibinqo	abrocitinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	Atopic dermatitis, moderate to severe	Reimburse with clinical criteria and/or conditions	Complete	Apr 26, 2021	Aug 19, 2022	SR0686-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1 - 25 of 596

Please scroll or swipe to the right to view the full content.

Title Sort descending	Description	Files	Last Updated	Project Sub Line	Status	Project Number
Gabapentin for Seizures		Gabapentin for Seizures	Oct 25, 2024	Rapid Review	Completed	RC1557-000
Renal Denervation		Renal Denervation	Apr 10, 2024	Rapid Review	Completed	RC1532-000
Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation		Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation	Aug 22, 2023	Rapid Review	Completed	RC1500-000
Abiraterone Acetate for Metastatic Castrate Sensitive Prostate Cancer		Abiraterone Acetate for Metastatic Castrate Sensitive Prostate Cancer	Jun 2, 2021	Peer-reviewed Summary with Critical Appraisal	Completed	RD0060-000
Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement: A Review of Clinical Effectiveness and Guidelines		RC1304 ASA for VTE Final.pdf	Aug 31, 2020	Summary with Critical Appraisal		RC1304-000
Adalimumab for Adult Patients with Crohn’s Disease: A Review of Clinical Effectiveness		RC1272 Adalimumab for Crohns Final.pdf	May 14, 2020	Summary with Critical Appraisal		RC1272-000
Adalimumab for Adult Patients with Plaque Psoriasis: A Review of Clinical Effectiveness		RC1274 Adalimumab for Plaque Psoriasis Final.pdf	Jun 22, 2020	Summary with Critical Appraisal	Completed	RC1274-000
Adalimumab for Adult Patients with Rheumatological Disorders: A Review of Clinical Effectiveness		RC1273 Adalimumab for Rheumatology Final erratum.pdf	Jun 2, 2020	Summary with Critical Appraisal	Completed	RC1273-000
Adalimumab for the Treatment of Adults With Non-Infectious Uveitis		Adalimumab for the Treatment of Adults With Non-Infectious Uveitis	Jan 24, 2022	Rapid Review	Completed	RD0063-000
Adalimumab for the Treatment of Pediatric Populations With Non-Infectious Uveitis		Adalimumab for the Treatment of Pediatric Populations With Non-Infectious Uveit…	Mar 16, 2022	Rapid Review	Completed	RD0064-000
Aerosol Therapy With Inhalers During Mechanical Ventilation		Aerosol Therapy With Inhalers During Mechanical Ventilation	Mar 12, 2024	Rapid Review	Completed	RC1529-000
Aging in Place	Our Health Technology Expert Review Panel convened to develop objective, impartial, trusted pan-Canadian guidance to inform decisions about which evidence-informed, equitable, aging in place initiatives across jurisdictions can support aging in place in Canada.	Evidence Assessment Report Supporting Information Summary of Engagement Activities Guidance	Dec 13, 2023	Optimal Use	Active	OP0555-000
Airway Management in Out-of-Hospital Emergencies		Airway Management in Out-of-Hospital Emergencies	Oct 21, 2024	Rapid Review	Completed	RC1555-000
Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An Update		Airway Pressure Release Ventilation for Acute Respiratory Distress Syndrome: An…	Sep 15, 2022	Rapid Review	Completed	RC1451-000
Alemtuzumab, Cladribine, Fingolimod, and Natalizumab as First-Line Treatments in Adult Patients With Highly Active Relapsing Multiple Sclerosis		Final Report Project Protocol	May 30, 2024	Health Technology Assessment	Completed	HT0038-000
Alternate level of care (ALC)			Aug 26, 2024	Optimal Use	Active	OP0557-000
Alternative Therapies to Immunoglobulin for Autoimmune Blistering Diseases		Alternative Therapies to Immunoglobulin for Autoimmune Blistering Diseases	May 29, 2023	Summary with Critical Appraisal	Completed	RC1483-000
Alternative Therapies to Immunoglobulin for Guillain-Barré Syndrome		Alternative Therapies to Immunoglobulin for Guillain-Barré Syndrome	May 15, 2023	Rapid Review	Completed	RC1480-000
Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies		Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies	Jun 29, 2023	Rapid Review	Completed	RC1484-000
Alternative Therapies to Immunoglobulin for Multifocal Motor Neuropathy		Alternative Therapies to Immunoglobulin for Multifocal Motor Neuropathy	Apr 21, 2023	Rapid Review	Completed	RC1479-000
An Analysis of Demographic and Utilization Patterns of Patients Accessing Emergency Departments in Canada		Emergency Department Overcrowding: Utilization Analysis Emergency Department Overcrowding: Utilization Analysis: Methods Document	Nov 28, 2023	Technology Review	Complete	HC0061-000
An Inventory of Rare Disease Registries in the Canadian Landscape		An Inventory Report of Rare Disease Registries in the Canadian Landscape	Aug 29, 2024	Environmental Scan	Completed	CP0033-000
Anakinra Therapy for Hemophagocytic Lymphohistiocytosis		Anakinra Therapy for Hemophagocytic Lymphohistiocytosis	Feb 16, 2022	Rapid Review	Completed	RC1409-000
Analysis of FPT Formulary Harmonization: Specialty Care Medications		Analysis of FPT Formulary Harmonization: Specialty Care Medications	May 12, 2021	Technology Review	Completed	HD0005-000
Anesthesia Care Provided by Nurses		Anesthesia Care Provided by Nurses	Sep 2, 2021	Rapid Review		RC1376-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1 - 25 of 110

Please scroll or swipe to the right to view the full content.

Title Sort descending	Description	Files	Last Updated	Project Sub Line	Status	Project Number
Hearing Aids and Dementia		Hearing Aids and Dementia	Jul 6, 2023	Emerging Health Technologies	Completed	EH0120-000
Pharyngeal Electrical Stimulation Device for the Treatment of Dysphagia Associated With Neurologic Conditions		Pharyngeal Electrical Stimulation Device for the Treatment of Dysphagia Associ…	Sep 22, 2021	Health Technology Update	Completed	EN0030-000
2021 Health Technology Trends to Watch		ER0011 Horizon Scanning 2021 Tech Trends v8.0.pdf	Feb 4, 2021	Roundup	Completed	ER0011-000
2022 Health Technology Trends to Watch		2022 Health Technology Trends to Watch	Mar 16, 2022	Roundup	Completed	ER0012-000
2024 Watch List: Care for Children and Youth With Medical Complexity	The 2024 Watch List aims to identify and describe technologies and issues related to the care of children and youth with medical complexity that are likely to affect health care delivery and planning in Canada in the next 5 years.	2024-watch-list-report.pdf	Mar 5, 2024	Roundup	Completed	ER0014-000
2025 Watch List: Artificial Intelligence			Aug 20, 2024		In Progress	ER0015-000
A Virtual Waiting Room? Technologies That Limit Contact While Maintaining Patient Flow in Medical Practice Settings		en0019-topic1.pdf	Aug 21, 2020	Health Technology Update	Completed	EN0019-000
Adaptive Deep Brain Stimulation for the Treatment of Parkinson Disease and Essential Tremor		Adaptive Deep Brain Stimulation for the Treatment of Parkinson Disease and Esse…	Dec 2, 2021	Health Technology Update	Completed	EN0036-000
Alternating Electric Fields ("Tumour- Treating Fields") for the Treatment of Glioblastoma			Jan 16, 2018	Emerging Health Technologies	Completed	EH0060-000
An Overview of Clinical Applications of Artificial Intelligence			Oct 1, 2018	Emerging Health Technologies	Completed	EH0070-000
An Overview of Clinical Applications of Virtual and Augmented Reality		An Overview of Clinical Applications of Virtual and Augmented Reality	Jul 31, 2023	Emerging Health Technologies	Completed	EH0111-000
An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care		An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Ca…	Aug 10, 2022	Emerging Health Technologies	Completed	EH0106-000
An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices		An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devi…	May 24, 2022	Emerging Health Technologies	Completed	EH0102-000
An Overview of Emerging Point-of-Care Tests for Differentiating Bacterial and Viral Infections		An Overview of Emerging Point-of-Care Tests for Differentiating Bacterial and V…	Dec 14, 2021	Emerging Health Technologies	Completed	EH0097-000
An Overview of Emerging Trends and Technologies in Ulcerative Colitis		An Overview of Emerging Trends and Technologies in Ulcerative Colitis	Jul 31, 2023	Emerging Health Technologies	Complete	EH0117-000
An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease		An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer D…	May 16, 2022	Emerging Health Technologies	Completed	EH0103-000
An Overview of Pharmacogenomic Testing for Psychiatric Disorders		An Overview of Pharmacogenomic Testing for Psychiatric Disorders	Jun 6, 2023	Emerging Health Technologies	Completed	EH0115-000
An Overview of Post‒COVID-19 Condition (Long COVID)		An Overview of Post‒COVID-19 Condition (Long COVID)	Sep 24, 2021	Emerging Health Technologies	Completed	EH0096-000
An Overview of Smartphone Apps		Horizon Scan	Feb 22, 2022	Emerging Health Technologies	Completed	EH0098-000
Artificial Intelligence Decision Support Tools for End-of-life Care Planning Conversations		Artificial Intelligence Decision Support Tools for End-of-life Care Planning Conversations	Dec 22, 2023	Health Technology Update	Completed	EN0053-000
Artificial Intelligence for Patient Flow	Our Horizon Scan explores artificial intelligence-based patient flow management tools that forecast and monitor patient movements from admission to discharge as they progress through different care settings.	Artificial Intelligence for Patient Flow	May 2, 2024	Emerging Health Technologies	Completed	EH0125-000
Artificial Intelligence for the Prediction of Sepsis in Adults		Artificial Intelligence for the Prediction of Sepsis in Adults	Mar 14, 2022	Health Technology Update	Completed	EN0034-000
Artificial Intelligence in Prehospital Emergency Health Care	Health care systems in Canada, including prehospital emergency health care services, are facing staffing shortages and increased patient volumes, and are looking for creative solutions to ensure the provision of high-quality care.	Artificial Intelligence in Prehospital Emergency Health Care	Aug 18, 2023	Health Technology Update	Completed	EN0052-000
Artificial Intelligence– Enhanced Rapid Response Electroencephalography for the Identification of Nonconvulsive Seizure		Artificial Intelligence– Enhanced Rapid Response Electroencephalography for the Identification of Nonconvulsive Seizure	Jan 9, 2024	Health Technology Update	Completed	EN0054-000
Autologous Hematopoietic Stem Cell Transplant for People With Multiple Sclerosis		HTERP Guidance Statement – AHSCT for treatment of Multiple Sclerosis Horizon Scan - Bulletin	Jul 20, 2022	Optimal Use	Complete	EH0093 / OP0551

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1 - 25 of 30

Please scroll or swipe to the right to view the full content.

Title Sort descending	Files	Last Updated	Project Line	Project Sub Line	Project Number
2025 Watch List: Artificial Intelligence		Aug 20, 2024	Horizon Scan		ER0015-000
Acute Myeloid Leukemia	Proposed Scope	Jan 23, 2025	Reimbursement Review	Provisional Funding Algorithm	PH0082-000
Antiviral Drugs for the Treatment of Suspected or Confirmed Influenza A or Influenza B		Dec 16, 2024	Health Technology Review	Systematic Review	RE0052-000
Appraisal of RWE submitted for health technology assessment		Jun 28, 2024	Health Technology Review		MG0028-000
Benchmarking CT and MRI exams		Nov 21, 2024	Health Technology Review		CM0016-000
Breast Cancer	Proposed Scope	Jan 23, 2025	Reimbursement Review	Provisional Funding Algorithm	PH0083-000
Criteria for conducting Environmental Assessments in CADTH HTAs		Jun 5, 2019	Health Technology Review		MG0017-000
Cystic Fibrosis		Jun 28, 2024	Health Technology Review		HM0005-000
Dosing of Immune Checkpoint Inhibitors		Mar 11, 2025	Health Technology Review	Systematic Review	RE0053-000
Formulary Management of Targeted Immune Modulators for Ulcerative Colitis		Jun 24, 2022	Health Technology Review	Technology Review	HD0010-000
Health Technology Assessment Recommendations and Managed Entry Agreements Related to Optimizing the Treatment for Pediatric Spinal Muscular Atrophy		Aug 17, 2022	Health Technology Review	Environmental Scan	ES0368-000
Immune checkpoint inhibitors for mutated non–small cell lung cancer		Jan 15, 2024	Health Technology Review	Observational Study	OS0008-000
Interventions for the treatment of obstructive sleep apnea: economic update		Jul 29, 2022	Health Technology Review	Technology Review	HE0038-000
Methodology for Ethics Analysis in Pharmaceutical Reimbursement Reviews		Jun 28, 2024	Health Technology Review		MG0027-000
Natural Cycles App as Contraception		Jun 28, 2024	Horizon Scan	Health Technology Update	EN0057-000
Newborn screening - Drugs for Rare Diseases Strategy		Jun 28, 2024	Health Technology Review	Technology Review	HC0079-000
Optimal installation of DI equipment		Jun 28, 2024	Health Technology Review		CM0013-000
Optimal Wait Times		Nov 21, 2024	Health Technology Review		CM0014-000
Optimizing ultrasound booking schedules		Jul 16, 2024	Health Technology Review		CM0021-000
Patterns in Utilization of Long-Acting Inhaled Drugs for the Treatment of Chronic Obstructive Pulmonary Disease		Apr 1, 2024	Health Technology Review	Technology Review	HC0086 -000
PET-CT Comparisons 2020-2024		Jun 28, 2024	Health Technology Review		CM0006-000
Policies for Pediatric Medicines		Mar 10, 2023	Health Technology Review	Environmental Scan	ES0376-000
Re-treatment With Immune Checkpoint Inhibitors: Utilization Analysis		Oct 16, 2024	Health Technology Review	Technology Review	HC0093-000
RWE Learning Project Non-Oncology: Ocaliva		Sep 8, 2022	Health Technology Review	Technology Review	HC0046-000
Transition from alteplase (tPA) to tenecteplase (TNK) for thrombolysis for acute ischemic stroke		Dec 23, 2022	Health Technology Review	Policy Insight	CY0015-000

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1 - 25 of 2119

Please scroll or swipe to the right to view the full content.

Title Sort descending	Description	Files	Last Updated	Project Line	Project Sub Line	Status	Project Number
dabrafenib trametinib			Nov 10, 2023	Reimbursement Review		Cancelled	PC0337-000
Gabapentin for Seizures		Gabapentin for Seizures	Oct 25, 2024	Health Technology Review	Rapid Review	Completed	RC1557-000
Hearing Aids and Dementia		Hearing Aids and Dementia	Jul 6, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0120-000
Ninlaro for Multiple Myeloma (2nd-beyond) – Details		pcodr-provfund-10164-ixazomib-ninlaro_mm2nd-beyond.pdf 10164IxazomibMM_fnRec_2019-07-05_ChairApproved_Post_05Jul2019_final.pdf 10164IxazomibMM_fnEGR_NOREDACT-ABBREV_Post_05Jul2019_final.pdf 10164IxazomibMM_fnCGR_REDACT_Post_05Jul2019_final.pdf 10164IxazomibMM_inRec_2019-05-03_Approved_Post_03May2019_final.pdf 10164IxazomibMM_PAGFeedbackSummary_FINAL_Post_5Jul2019_final.pdf 10164IxazomibMM_SubmitterFeedback_2019-05-17_Post_05Jul2019_final.pdf 10164IxazomibMM_PatientFeedback_MC_2019-05-15_Post_05Jul2019_final.pdf 10164IxazomibMM_ClinicianFeedback_CCO_2019-05-16_Post_05Jul2019_final.pdf 10164IxazomibMM_Patient_COI_MC_2018-12-13_Post_05Jul2019_final_Redacted.pdf 10164IxazomibMM_Combined COIs_Post_05Jul2019_final Redacted.pdf	Jul 22, 2019	Reimbursement Review		Complete	PC0164-000
Niraparib (Zejula) for first line Ovarian Cancer - Details		10224NiraparibOC_fnRec_pERC Chair Approved_Post29Apr2021_final.pdf 10224NiraparibOC_fnEGR_REDACT-ABBREV_Post29Apr2021_final.pdf 10224NiraparibOC_fnCGR_NOREDACT_Post29Apr2021_final.pdf 10224NiraparibOC_inRec_pERC Chair Approved_Post04Mar2021_final.pdf 10224NiraparibOC_PAGFeedbackSummary_Post29Apr2021_final_Redacted.pdf 10224NiraparibOC_SponsorFeedback_Post29Apr2021_final.pdf 10224NiraparibOC_PatientFeedback_OCC_Post29Apr2021_final.pdf 10224NiraparibOC_ClinicianFeedback_CCO_Post29Apr2021_final.pdf 10224NiraparibOC_Patient COI_OCC_Post29Apr2021_final.pdf 10224NiraparibOC_Combined Clinician COIs_Post29Apr2021_final.pdf	Apr 29, 2021	Reimbursement Review		Complete	PC0224-000
Pembrolizumab (Keytruda) for Renal Cell Carcinoma — Details		10185PembrolizumabRCC_fnRec_2020-03-31_ApprovedpERCChair_Post02Apr2020_final.pdf 10185PembrolizumabRCC_fnEGR_NOREDACT-ABBREV_Post02Apr2020_final.pdf 10185PembrolizumabRCC_fnCGR_REDACT_Post02Apr2020_final.pdf 10185PembrolizumabRCC_PAGFeedbackSummary_Post02Apr2020_final.pdf 10185PembrolizumabRCC_SponsorFeedback_Post24Mar2020_final.pdf 10185PembrolizumabRCC_ClinicianFeedback_CCOGUDAC_Post02Apr2020_final_Redacted.pdf 10185PembrolizumabRCC_PatientInput_KCC_COI_Post02Apr2020_final_Redacted.pdf 10185PembrolizumabRCC_Combined COIs_Post02Apr2020_final_Redacted.pdf Pembrolizumab (Keytruda) RCC – pERC Initial Recommendation	Apr 20, 2020	Reimbursement Review		Complete	PC0185-000
Pharyngeal Electrical Stimulation Device for the Treatment of Dysphagia Associated With Neurologic Conditions		Pharyngeal Electrical Stimulation Device for the Treatment of Dysphagia Associ…	Sep 22, 2021	Horizon Scan	Health Technology Update	Completed	EN0030-000
Renal Denervation		Renal Denervation	Apr 10, 2024	Health Technology Review	Rapid Review	Completed	RC1532-000
Sonidegib (Odomzo) for Basal Cell Carcinoma - Details		10215SonidegibBCC_fnRec_Post29Apr2021_final.pdf 10215SonidegibBCC_fnEGR_NOREDACT-ABBREV_Post29Apr2021_final.pdf 10215SonidegibBCC_fnCGR_NOREDACT_Post29Apr2021_final.pdf 10215SonidegibBCC_inRec_Post04Mar2021_final.pdf 10215SonidegibBCC_PAGFeedbackSummary_Post29Apr2021_final.pdf 10215SonidegibBCC_SponsorFeedback_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_PatientFeedback_Combined_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_ClinicianFeedback_CCO_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_PatientCOI_Combined_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_ClinicianInput_Combined_COIs Post29Apr2021_final_Redacted.pdf	Apr 29, 2021	Reimbursement Review		Complete	PC0215-000
Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation		Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation	Aug 22, 2023	Health Technology Review	Rapid Review	Completed	RC1500-000
Xtandi for non-metastatic Castration-Resistant Prostate Cancer – Details		pcodr_profund_enzalutamide_xtandi_non-mcrpc_10149.pdf 10149Enzalutamidenm-CRPC_FnRec_EarlyConv_2019-03-26-v4_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_fnCGR_EC_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_fnEGR_EC_NOREDACT-ABBREV_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_InRec_approvedbyChair_NOREDACT_Post_07Mar2019_final.pdf 10149Enzalutamide_nmCRPC_PAGFeedbackSummary_FINAL_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_SubmitterFeedback_2019-03-21_Post_26Mar2019_final.pdf 10149Enzalutamidenm-CRPC_ClinicianFeedback_CCO_2019-03-21_Post_26Mar2019_final.pdf 10149Enzalutamide-CRPC_COI_CCSN_Post_26Mar2019_final_Redacted.pdf 10149EnzalutamidenmCRPC_Combined_Clinician_COI_Post_26Mar2019_final.pdf	Apr 10, 2019	Reimbursement Review		Complete	PC0149-000
2021 Health Technology Trends to Watch		ER0011 Horizon Scanning 2021 Tech Trends v8.0.pdf	Feb 4, 2021	Horizon Scan	Roundup	Completed	ER0011-000
2022 Health Technology Trends to Watch		2022 Health Technology Trends to Watch	Mar 16, 2022	Horizon Scan	Roundup	Completed	ER0012-000
2024 Watch List: Care for Children and Youth With Medical Complexity	The 2024 Watch List aims to identify and describe technologies and issues related to the care of children and youth with medical complexity that are likely to affect health care delivery and planning in Canada in the next 5 years.	2024-watch-list-report.pdf	Mar 5, 2024	Horizon Scan	Roundup	Completed	ER0014-000
2025 Watch List: Artificial Intelligence			Aug 20, 2024	Horizon Scan		In Progress	ER0015-000
A Virtual Waiting Room? Technologies That Limit Contact While Maintaining Patient Flow in Medical Practice Settings		en0019-topic1.pdf	Aug 21, 2020	Horizon Scan	Health Technology Update	Completed	EN0019-000
Abacavir/lamivudine		cdr_tracking_Kivexa.pdf cdr_complete_Kivexa_Dec605.pdf	Jul 26, 2005	Reimbursement Review		Complete	SR0038-000
abaloparatide			Nov 4, 2022	Reimbursement Review		Withdrawn	SR0744-000
Abatacept		cdr_tracking_Orencia.pdf cdr_complete_Orencia_June-27-2007.pdf	Oct 26, 2006	Reimbursement Review		Complete	SR0084-000
Abatacept		cdr_Orencia_New_Indication.pdf cdr_complete_Orencia_Final_April 24_2009.pdf	Aug 29, 2008	Reimbursement Review		Complete	SR0145-000
Abatacept		cdr_tracking_Orencia_RA.pdf cdr_complete_Orencia-RA_July-22-13_e.pdf	Nov 29, 2012	Reimbursement Review		Complete	SR0299-000
Abatacept		cdr_tracking_Orencia_Resubmission-1.pdf cdr_complete_Orencia-Resubmission_June-17-2010.pdf	Dec 2, 2009	Reimbursement Review		Complete	SR0187-000
abemaciclib		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Dec 23, 2022	Reimbursement Review		Complete	PC0282-000
abemaciclib		Recommendation and Reason Patient and Clinician Group input Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation	Feb 7, 2025	Reimbursement Review		Complete	PC0345-000
abemaciclib		Patient and Clinician Group input	Mar 12, 2025	Reimbursement Review		Active	PC0409-000